Showing 5,959 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Bone & joint problems

Heroin use, AIDS, predict reduced bone mineral density in older men with HIV

News
24 August 2010
New & experimental HIV treatments

Researchers Identify Two FDA Approved Drugs That May Fight HIV

Editor's pick
Science Daily
24 August 2010
People who inject drugs

Sexual risk behaviour doesn’t increase in injecting drug users who start HIV treatment

News
19 August 2010
Cardiovascular disease

Traditional risk factors main cause of thickening of carotid artery in patients with HIV

News
18 August 2010
New & experimental HIV treatments

Maraviroc potentially of benefit for many patients with late HIV diagnosis

News
16 August 2010
Ageing & HIV

New diagnoses among over 50s double in England, Wales and Northern Ireland

News
16 August 2010
Kidney problems

Tenofovir treatment impairs kidney function, but clinical significance limited

News
16 August 2010
Mental & emotional health problems

Symptoms can predict increases in viral load for patients taking HIV treatment

News
9 August 2010
Starting treatment

FDA Approves New Labeling For ISENTRESS® To Include 96-Week Efficacy And Tolerability Data In Adult Patients Infected With HIV-1

Editor's pick
Medical News Today
6 August 2010
Changing treatment

AFRICA/ASIA: Worrying rates of second-line treatment failure

Editor's pick
IRIN Plus News
4 August 2010
Government, leadership & policy

Lymphocyte count and haemoglobin can predict prognosis of patients starting ART

News
3 August 2010
Treatment outcomes & life expectancy

Outcomes still improving for HIV patients in the UK

News
2 August 2010
New & experimental HIV treatments

Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir

Editor's pick
PR Newswire
28 July 2010
New & experimental HIV treatments

Therapeutic HIV vaccines show promise

Editor's pick
Scientific American
28 July 2010
Epidemiology

'The business of public health': new research on financing of HIV programmes

News
27 July 2010
New & experimental HIV treatments

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

News
26 July 2010
Neurological & cognitive problems

Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

News
26 July 2010
Starting treatment

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

News
23 July 2010
New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
Drug interactions & pharmacokinetics

IAC: Smoking Has No Impact on Atazanavir Levels

Editor's pick
MedPage Today
22 July 2010
Changing treatment

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

News
22 July 2010
Pregnancy, children & young people

Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

News
22 July 2010